Showing results (341-350 of 381) with videos related to
Sort By:
Pageof 39
The Journal of Sports Medicine and Physical Fitness|July 12, 2001
Mechanomyography, electromyography, heart rate, and ratings of perceived exertion during incremental cycle ergometryS R Perry, T J Housh, G O Johnson, et al.Nanotechnology|October 25, 2012
Characterization of hydrogen responsive nanoporous palladium films synthesized via a spontaneous galvanic displacement reactionJ F Patton, N V Lavrik, D C Joy, et al.Virus Genes|December 29, 2000
Diversity of hepatitis G virus within a single infected individualL Shao, H Shinzawa, X Zhang, et al.Neurology|January 1, 1982
Pseudoseizures: diagnostic evaluationD W King, B B Gallagher, A J Murvin, et al.Psychiatric Services (Washington, D.C.)|November 3, 2020
Lagniappes: "A Little Something Extra" or Unintended Positive Consequences of Implementation FacilitationEva N Woodward, Karen L Drummond, Karen Anderson Oliver, et al.The Journal of General Virology|February 17, 2000
Phylogenetic analysis of GBV-C/hepatitis G virusD B Smith, M Basaras, S Frost, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
Increasing and planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) by adding recombinant human methionyl granulocyte colony-stimulating factor (G-CSF; filgrastim) in the treatment of small cell lung cancer (SCLC). Medical Research Council Lung Cancer Working PartyN Thatcher, P I Clark, D B Smith, et al.Current Medical Research and Opinion|August 9, 2005
Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trialR M Fleischmann, S B Cohen, L W Moreland, et al.European Journal of Cancer (Oxford, England : 1990)|February 1, 1990
Quantitative distribution of 131I-labelled monoclonal antibodies administered by the intra-ventricular routeD B Smith, R P Mosely, R H Begent, et al.Hematological Oncology|July 1, 1987
VAD chemotherapy--toxicity and efficacy--in patients with multiple myeloma and other lymphoid malignanciesH Anderson, J H Scarffe, M Lambert, et al.Pageof 39